NPM1 and acute myeloid leukemia: NPM1-mutated AML displays peculiar biological and clinical features [1,2] that lead to its inclusion as a provisional entity first, and then as a definitive distinct entity in the World Health Organization (WHO) classification of the myeloid neoplasms [3].